Parent Categories
Health Care
-
Transparency in Health and Health Care in the United States: Law and Ethics (Holly Fernandez Lynch, I. Glenn Cohen, Carmel Shachar & Barbara J. Evans…
-
Divergent Human Rights Approaches to Capacity and Consent
February 7, 2025
Gerald L. Neuman, Divergent Human Rights Approaches to Capacity and Consent, in, Mental Health, Legal Capacity, and Human Rights (Charlene Sunkel, Faraaz Mahomed, Michael Ashley…
-
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement
February 6, 2025
Amy L. McGuire, I. Glenn Cohen, Dominic Sisti et al., Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement, 7 JAMA…
-
Microdosing Psychedelics Under Local, State, and Federal Law
February 6, 2025
Mason Marks, I. Glenn Cohen, Jonathan Perez- Reyzin et al., Microdosing Psychedelics Under Local, State, and Federal Law, 103 B.U. L. Rev. 101 (2023).
-
Providing Responsible Health Care for Out-of-State Patients
February 5, 2025
Carmel Shachar, Barak D. Richman & Ateev Mehrotra, Providing Responsible Health Care for Out-of-State Patients, 330 JAMA 499 (2023).
-
Digital Inclusion as Health Care — Supporting Health Care Equity with Digital-Infrastructure Initiatives
February 5, 2025
Jorge A. Rodriguez, Carmel Shachar & David W. Bates, Digital Inclusion as Health Care — Supporting Health Care Equity with Digital-Infrastructure Initiatives, 386 New England…
-
Carmel Shachar & Sara Gerke, Prevention of Bias and Discrimination in Clinical Practice Algorithms, 329 JAMA 283 (2023).
-
Mason Marks & Carmel Shachar, Drug scheduling limits access to essential medicines and should be reformed, 29 Nature Med. 294 (2023).
-
Reconsidering Health Care Fraud and Abuse Laws
February 5, 2025
Carmel Shachar & Gregory Curfman, Reconsidering Health Care Fraud and Abuse Laws, 324 JAMA 1735 (2020).
-
Ten Considerations for Effectively Managing the COVID-19 Transition
February 5, 2025
Katrine Bach Habersaat, Cornelia Betsch, Margie Danchin, Cass R. Sunstein, Robert Böhm, Armin Falk, Noel T. Brewer, Saad B. Omer, Martha Scherzer, Sunita Sah et…
-
The Clinician and Dataset Shift in Artificial Intelligence
February 5, 2025
Samuel G. Finlayson, Adarsh Subbaswamy, Karandeep Singh, John Bowers, Annabel Kupke, Jonathan Zittrain, Isaac S. Kohane & Suchi Saria, The Clinician and Dataset Shift in…
-
Observational Studies must be Reformed before the Next Pandemic
February 5, 2025
Emily E. Ricotta, Annette Rid, I. Glenn Cohen et al., Observational Studies must be Reformed before the Next Pandemic, 29 Nature Med. 1903 (2023).
-
How Should the FDA Evaluate Psychedelic Medicine?
February 5, 2025
Mason Marks & I. Glenn Cohen, How Should the FDA Evaluate Psychedelic Medicine?, 389 New England J. Med. 1733 (2023).
-
Psychedelic Therapy: A Roadmap for Wider Acceptance and Utilization
February 5, 2025
Mason Marks & I. Glenn Cohen, Psychedelic Therapy: A Roadmap for Wider Acceptance and Utilization, 27 Nat. Med. 1669 (2021).
-
Skating the line between general wellness products and regulated devices: strategies and implications
February 5, 2025
David A. Simon, Carmel Shachar & I. Glenn Cohen, Skating the line between general wellness products and regulated devices: Strategies and implications, 9 J. L.
-
Machine Learning in Medicine: Addressing Ethical Challenges
February 4, 2025
Effy Vayena, Alessandro Blasimme & I. Glenn Cohen, Machine Learning in Medicine: Addressing Ethical Challenges, 15 PLoS Med. e1002689 (2018).
-
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
February 4, 2025
Soumitri Barua, Robert Greenwald, Jason Grebely, Gregory J. Dore, Tracy Swan & Lynn E. Taylor, Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of…
-
Testing for AIDS: Uses and Abuses
February 4, 2025
Martha A. Field, Testing for AIDS: Uses and Abuses, 16 Am. J.L. & Med. 400 (1990).